Hemodynamic Phenotype and Capillary Refill Time-targeted Resuscitation Strategy
NCT05057611 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1500
Last updated 2024-07-22
Summary
Septic shock is associated with a high mortality risk. Fluid overload occurs when fluids are administered to fluid unresponsive patients, but also when inappropriate resuscitation goals are pursued. Alongside, evidence confirms that abnormal peripheral perfusion after resuscitation is associated with increased morbidity and mortality. Targeted resuscitation associates with lower mortality, less organ dysfunction, and less intensity of treatment. Over-resuscitation may contribute to a worse outcome.
Many patients remain hypovolemic after initial resuscitation. Others present very low diastolic arterial pressures (DAP) reflecting profound vasoplegia and may benefit from early norepinephrine (NE) instead of fluids. Administering fluids in this setting could increase the risk of fluid overload. In addition, relevant myocardial dysfunction is present in a significant number of patients. Pulse pressure (PP) and DAP evaluation may help clinicians to individualize initial management sparing unnecessary fluid loading.
Objective: To test if a CRT-targeted resuscitation based on clinical hemodynamic phenotyping can improve a hierarchical clinical outcome - mortality, time to cessation of vital support, and length of hospital stay, all within 28 days - in septic shock patients as compared to usual care.
A2 is a multicenter randomized controlled trial (RCT) comparing a CRT-targeted, hemodynamics-based resuscitation strategy with usual care in patients with early septic shock during a 6 h intervention period. A sample size of 1500 patients was calculated to detect a 6% absolute reduction in mortality in the CRT group, and the win-ratio method will be used to test the superiority in the hierarchical outcomes mentioned above.
The combination of a CRT-targeted strategy with a clinical hemodynamic phenotyping may aid to personalize initial resuscitation with potential additional fluid-sparing effects. To categorize patients at baseline according to PP may conduct patients with low PP (\<40mmHg) to fluid responsiveness (FR) assessment and eventually fluid boluses, while patients with normal PP will be treated according to DAP, adjusting NE when to avoid further fluids loading in patients who normalize CRT.
Fluid resuscitation will be focused on FR+ hypoperfused patients to prevent harmful fluid administration in FR- patients.
Conditions
- Septic Shock
Interventions
- OTHER
-
CRT-targeted strategy associated with a clinical hemodynamic phenotyping to personalize initial resuscitation in septic shock patients
A combination of combine a CRT-targeted strategy with a clinical hemodynamic phenotyping that may aid to personalize initial resuscitation with potential additional fluid-sparing effects.
- OTHER
-
Usual care (UC)
\- Patients allocated to the UC group will be managed by the clinical staff according to usual practice at their sites including decisions about hemodynamic and perfusion monitoring, and all treatments, but should follow general recommendations of the Surviving Sepsis Campaign to avoid extremes of clinical practice. This includes basic hemodynamic targets such as a MAP \>65 mmHg, heart rate (HR) \<120 beats per minute (BPM), arterial oxygen saturation (SaO2) \>94%, Hb \> 7 gr/dl, and the use of NE as the first vasopressor and crystalloids as the fluid of choice.
Sponsors & Collaborators
-
Fundacion Clinica Valle del Lili
collaborator OTHER -
Hospital do Coracao
collaborator OTHER - collaborator OTHER
-
Pontificia Universidad Catolica de Chile
lead OTHER
Principal Investigators
-
Glenn Hernandez, MD, PhD · Pontificia Universidad Catolica de Chile
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-18
- Primary Completion
- 2025-03-30
- Completion
- 2025-06-30
Countries
- Chile
Study Locations
More Related Trials
-
Effects of Fluid Therapy on Peripheral TIssse Perfusion During Sepsis/Septic Shock
NCT05094856 ·Status: COMPLETED
-
Does the Time Between the End of Vascular Filling and Evaluation of Its Effectiveness Modify Fluid Challenge Results in Septic Shock?
NCT02116413 ·Status: COMPLETED
-
Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care
NCT02079402 ·Status: COMPLETED ·Phase: PHASE4
-
Metabolic Cluster Analysis in Septic Shock Patients
NCT06500156 ·Status: RECRUITING
-
Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis
NCT03434028 ·Status: COMPLETED ·Phase: PHASE3
-
Timing of Preload Responsiveness in Sepsis
NCT05627817 ·Status: UNKNOWN
-
Capillary Refill Time Response to a Rapid Fluid Challenge in Septic Shock Patients
NCT04693923 ·Status: UNKNOWN ·Phase: NA
-
Monitoring Resuscitation in Severe Sepsis and Septic Shock
NCT01747057 ·Status: UNKNOWN ·Phase: NA
-
Effect of Dynamic Arterial Elastance and Assisted Fluid Management Software Guided Resuscitation in Septic Shock: Pilot Study
NCT06937918 ·Status: RECRUITING ·Phase: NA
-
Assessment of Fluid Responsiveness in Septic Shock Patients, Can End-tidal co2 Measurement Help?
NCT05557461 ·Status: UNKNOWN
-
Efficacy of Targeted Abdominal Perfusion Pressure in Septic Shock
NCT05358912 ·Status: COMPLETED ·Phase: PHASE4
-
Preemptive Resuscitation for Eradication of Septic Shock
NCT01449721 ·Status: COMPLETED ·Phase: NA
-
Evolution of Tissue Perfusion and Venous Congestion Markers in Fluid-Responsive Septic Shock Patients
NCT06958809 ·Status: NOT_YET_RECRUITING
-
Protocol-driven Hemodynamic Support for Patients With Septic Shock
NCT00335907 ·Status: UNKNOWN ·Phase: NA
-
Microcirculatory Guided Goal Directed Fluid Therapy in Septic Shock; a Feasibility Study
NCT03898674 ·Status: UNKNOWN ·Phase: NA
-
Population Pharmacokinetics and Monte Carlo Dosing Simulations of Meropenem During the Early Phase of Severe Sepsis and Septic Shock in Critically Ill Patients in Intensive Care Units
NCT02213796 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Control Study in REsuscitation of SEpsis Trial
NCT07035509 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Effects of Norepinephrine and Volume Expansion in Capillary Refill Time in Septic Shock
NCT04870892 ·Status: UNKNOWN
-
CLinical Efficacy of Hemoperfusion With a Cytokine Adsorber in Norepinephrine-Resistant SEptic Shock
NCT05136183 ·Status: UNKNOWN ·Phase: NA
-
Australasian Resuscitation In Sepsis Evaluation: FLUid or Vasopressors In Emergency Department Sepsis
NCT04569942 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Ventriculo-arterial Coupling and Myocardial Work in Sepsis and Septic Shock
NCT06853574 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Safety and Efficacy of Extracorporeal Cytokine Hemoadsorption in Septic Shock in Critically Ill Cirrhotics
NCT03866083 ·Status: UNKNOWN ·Phase: NA
-
Effect of Different Strategies for Titrating a High MAP on Microcirculation
NCT02085291 ·Status: COMPLETED ·Phase: PHASE4
-
Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients With Septic Shock
NCT00279214 ·Status: COMPLETED ·Phase: PHASE4
-
The Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care Trial
NCT03668236 ·Status: COMPLETED ·Phase: PHASE4